Chosa Oncology AB (NGM: CHOSA)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Chosa Oncology AB (NGM: CHOSA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.31M.
trading between 0.30 and 2.60.
Tweenvest scores Chosa Oncology AB across four factors: quality 49/100. Its strongest factor is quality.
CHOSA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.31M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- Skr2.60
- 52-week low
- Skr0.30
- Avg volume (3M)
- —
- Shares outstanding
- 64.87M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dermata Therapeutics, Inc.NasdaqCM: DRMA | $3.46M | $0.86 | -15.69% |
| Lunai Bioworks Inc.NasdaqCM: LNAI | $3.43M | $0.68 | -44.68% |
| Ernexa Therapeutics Inc.NasdaqCM: ERNA | $3.41M | $2.09 | -12.92% |
| National Graphite Corp.OTCPK: NGRC | $3.41M | $0.02 | +5.24% |
| Affymax, Inc.OTCPK: AFFY | $3.10M | $0.04 | +2500.00% |
| Calidi Biotherapeutics, Inc.NYSEAM: CLDI | $3.09M | $0.84 | -18.74% |
| Restart Life Sciences Corp.CNSX: HEAL | $3.06M | CA$0.07 | -6.67% |
| GRI Bio, Inc.NasdaqCM: GRI | $3.02M | $1.38 | -20.69% |
Figures last refreshed Oct 18, 2026.